Neptune Technologies & Bioressources Inc. Daily Stock Analysis

Daily Stock Analysis, NEPT, Neptune Technologies & Bioressources Inc, priceseries

Neptune Technologies & Bioressources Inc. Daily Stock Analysis
Stock Information
Open
0.37
Close
0.34
High
0.37
Low
0.34
Previous Close
0.35
Daily Price Gain
-0.01
YTD High
0.56
YTD High Date
Jan 18, 2022
YTD Low
0.26
YTD Low Date
Feb 24, 2022
YTD Price Change
-0.08
YTD Gain
-19.40%
52 Week High
1.77
52 Week High Date
Mar 15, 2021
52 Week Low
0.26
52 Week Low Date
Feb 24, 2022
52 Week Price Change
-1.05
52 Week Gain
-75.65%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Nov 20. 2017
1.12
Dec 6. 2017
1.43
11 Trading Days
27.73%
Link
LONG
Dec 8. 2017
1.68
Dec 27. 2017
1.99
12 Trading Days
18.24%
Link
LONG
Dec 28. 2017
2.10
Jan 18. 2018
2.93
13 Trading Days
39.32%
Link
LONG
Mar 7. 2018
2.65
Mar 27. 2018
2.86
14 Trading Days
7.74%
Link
LONG
Aug 21. 2018
3.31
Sep 10. 2018
3.91
13 Trading Days
18.14%
Link
LONG
Jan 4. 2019
2.89
Jan 18. 2019
3.50
10 Trading Days
21.13%
Link
LONG
Apr 12. 2019
3.56
May 8. 2019
4.20
17 Trading Days
18.05%
Link
LONG
Jul 10. 2019
4.62
Jul 31. 2019
5.76
15 Trading Days
24.70%
Link
LONG
Apr 8. 2020
1.28
May 1. 2020
1.96
16 Trading Days
53.23%
Link
LONG
May 7. 2020
2.11
Jun 10. 2020
2.94
23 Trading Days
39.38%
Link
LONG
Jan 4. 2021
1.63
Jan 25. 2021
1.88
14 Trading Days
15.19%
Link
LONG
Feb 2. 2021
2.00
Feb 16. 2021
2.12
9 Trading Days
6.00%
Link
Company Information
Stock Symbol
NEPT
Exchange
NasdaqCM
Company URL
http://www.neptunebiotech.com
Company Phone
(450) 687-2262
CEO
James S. Hamilton
Headquarters
Quebec
Business Address
545 PROMENADE DU CENTROPOLIS, SUITE 100, LAVAL, CANADA H7T 0A3
Sector
Equity
Industry Category
Drugs
Industry Group
Biotechnology
CIK
0001401395
About

Neptune Technologies & Bioresources, Inc. engages in the development and commercialization of marine derived omega-3 polyunsaturated fatty acids. It operates through three segments: Neptune, Acasti and NeuroBio. The Neptune segment involves the production and commercialization of nutraceutical products. The Acasti segment involves the development and commercialization of medical food and pharmaceutical products for cardiovascular diseases. The NeuroBio segment involves the development of medical food and pharmaceutical products for neurological diseases. The company was founded by Henri Harland on October 9, 1998 and is headquartered in Laval, Canada.

Description

Neptune Technologies & Bioressources Inc., a biotechnology company, focuses on the research, development, and commercialization of products derived from marine biomasses for the nutraceutical and pharmaceutical industries. It produces marine-derived omega-3 polyunsaturated fatty acids, including Neptune Krill Oil (NKO), a dietary supplement for heart, joint, women, and brain health; ECOKRILL Oil (EKO), a krill product; and Neptune Krill Aquatein (NKA), a protein ingredient used in the production of nursing feed for young animals. The company is also developing CaPre, which is in Phase II clinical trials for the management of mild to moderate hypertriglyceridemia and severe hypertriglyceridemia, as well as develops and commercializes pharmaceutical applications for cardiovascular and neurological diseases. Neptune Technologies & Bioressources sells its products in Canada, the United States, France, Belgium, Australia, and other countries. The company was founded in 1925 and is headquartered in Laval, Canada.

TCHANNELS® is a Registered Trademark with USPTO

Some images used on this site have been taken from Unsplash

Legal Information

Useful Links

Contact Us

PO Box 2574, Sunnyvale
California 94087-0574, USA
Phone: 408-940-5056
Email: Click to send us an Email

Risks of Algorithmic Trading: Before investing please read our disclosure on Risks of Algorithmic Trading.

DISCLAIMER All investments entail inherent risk. This research seeks to assist investors in determining when to buy and when to sell to attempt to maximize profits or minimize losses. All final investment decisions are yours and as a result you could make or lose money. priceSeries.com, its employees and/or its affiliates and family members may from time to time take positions in the open market or otherwise with respect to the securities discussed. priceSeries.com, its employees and/or affiliates do not have stock ownership equal to or greater than 1% of the outstanding stock of the covered company nor does any employee of priceSeries.com sit on the Board of Directors of any covered company. priceSeries.com is not a broker/dealer, and the firm does not underwrite securities, manage assets or perform investment banking activities. The statements made herein include information obtained from sources believed to be reliable, but no independent verification has been made and we do not guarantee its accuracy or completeness.

U.S. Government Required Disclaimer - Commodity Futures Trading Commission
Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

2016 © priceSeries.com All Rights Reserved. Privacy Policy | Subscriber Agreement | Risks of Algorithmic Trading